“We are proud of our scientists and of the excellence of Italian research”, says the Minister. “Thanks to the European agreement, Italy will guarantee a vaccine to the people”, says Di Lorenzo (CEO of IRBM)
This morning the Health Minister Roberto Speranza, together with Andrea Magrini, the director general of Italian medicines agency AIFA, visited IRBM in Pomezia (Rome) and its researchers. Through its subsidiary Advent, the Italian company is collaborating on clinical trials with the Jenner Institute of Oxford University. “We are grateful to the Minister and to Prof. Magrini for their visit”, said Piero Di Lorenzo, President and CEO of IRBM. “Only a safe, effective vaccine can take us out of the emergency”, wrote Speranza on Facebook after visiting the laboratories in Pomezia. “We are proud of our scientists and of the excellence of Italian research”.
Article published on ilfoglio.it – 18/06/2020
Read the original article on ilfoglio.it[/vc_column_text][/vc_column][/vc_row]